[ad_1]
It’s been 10 years since Sun Pharmaceutical Industries forayed into specialty drugs. In 2012, it had acquired a US-based dermatology company, DUSA Pharmaceuticals, to get access to a specialty drug-device combination product, Levulan Kerastick. In those days, Indian companies were doing quite well in the US with their generic-drugs business, launching copy-cat versions of innovative branded drugs. Sun Pharma’s generic-drugs business was going
[ad_2]
Source link
